A man and woman walk into a Burger King. They order the same exact thing but pay two very different prices.

That's the premise of Burger King's new "Chick Tax" video. The hidden-camera video shows women's reactions when they're told that it'll cost them $3.09 for an order of Chicken Fries versus the $1.69 the man with them just paid.

Needless to say, many of the women in the video aren't happy about having to pay an extra $1.40 for the same product in pink packaging labeled "Chick Fries" — and rightly so. Ridiculous, right? Yeah, Burger King thought so too.

Keep Reading Show less
More

At the office at Patagonia, a retailer that sells outdoor clothing, the outcome of the 2016 election immediately brought concerns about climate change to mind.

Fighting global warming has been built in to the company's core mission for years. So it was alarming for many higher-ups at the retailer to wake up on Nov. 9, 2016, knowing that the new president-elect, Donald Trump, has said climate change is a hoax (despite overwhelming evidence saying otherwise).

A melting glacier drips away in Austria in August 2016. Photo by Sean Gallup/Getty Images.

Keep Reading Show less
Most Shared

In August 2016, pharmaceutical company Mylan became the latest health company to fall under fire for price gouging.

Over the course of seven years, they'd carefully managed to inflate the list price of EpiPen by nearly 500%, along with price-hikes on more than 30 other products too. That's pretty absurd, considering that some people, including fellow pharmaceutical-makers, say EpiPen ingredients are inexpensive and the pen can cost less than $20 to make. Plus, EpiPen already accounts for 40% of Mylan's operating profits.

At the height of this debacle, Mylan CEO Heather Bresch spoke with CNBC to offer insights on the inner workings of the pharmaceutical industry. And her answers actually revealed a lot about health care in America.

Keep Reading Show less
Family